Garré’s Osteomyelitis of the Jaw

Garré’s osteomyelitis of the jaws was first reported and defined by GarréCar in 1891 as a sclerotin disorder and characterized by chronic nonpurulent osteomyelitis with proliferative periostitis, mostly in adolescents with a mean age of 12.3 years [1–4]. Clinical manifestations include local painless swelling. It often involves unilateral mandible, a rare disease of the jaws. Besides, it is rarer with bilateral involvement. The imaging characteristics of Garré’s osteomyelitis of the jaws include dense bone sclerosis with periosteal new bone formation. The pathological changes of this disease are active subperiosteal osteogenesis with visible deposition of numerous osteoblasts. The etiology of Garré’s osteomyelitis of the jaws is related to odontogenic infection, endocrine and trauma [5–7]. Operation treatment with adjunctive systemic antibiotic therapy is the best regimen for Garré’s osteomyelitis of the jaws.